A Single-dose Open-Label Study to Assess the Safety and Preliminary Efficacy of PRF 110 in Open Herniorrhaphy Surgery
Status:
Completed
Trial end date:
2016-05-04
Target enrollment:
Participant gender:
Summary
LNP is new extended release (ER) oily solution formulation of ropivacaine that is intended
for local infiltration into surgical wounds. The purpose of this study is to determine the
ease of usage and administration of LNP in the surgical setting, to follow the
Pharmacokinetic (PK) profile of LNP over 72 hours and evaluate the duration of analgesia
witnessed in the surgical setting.